Please login to the form below

Not currently logged in
Email:
Password:

Egalet appoints Stan Musial as CFO

Joins US pharma company after a two-year spell as a start-up consultant

Stan Musial has joined US pharma company Egalet as chief financial officer having spent the past two years as an independent consultant for start-up businesses.

His most recent in-house role was as chief financial officer at Prism Pharmaceuticals, where he served from 2005 to 2011 before its sale to Baxter Healthcare.

Prior to joining Prism, Musial held the position of VP, finance, and chief financial officer for Strategic Diagnostics.

Egalet is a company that specialises in developing abuse-deterrent medication via a platform that prevents easy extraction and deters abuse of drugs through known routes, such as chewing, snorting, and injecting.

The company's president and chief executive Bob Radie said: "The addition of Stan to the management team comes at a critical time as the most advanced products in Egalet's pipeline of abuse-deterrent opioids are nearing phase III.

"Stan's finance experience will be invaluable as we move our pipeline through development and ultimately to the commercial market."

10th May 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics